Bristol Myers Squibb vs ChemoCentryx
Bristol Myers Squibb vs ChemoCentryx, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bristol Myers Squibb is on 22/100 and ChemoCentryx on 6/100.
Where each one leads
Bristol Myers Squibb
- our overall score: 22/100 against 6/100
- agent readiness: 44/100 against 21/100
- domain rating: 83/100 against 32/100
ChemoCentryx
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Bristol Myers Squibb | ChemoCentryx |
|---|---|---|
| What it is | A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. | Biopharmaceutical company focused on developing orally administered therapeutics for inflammatory disorders and cancer. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, Drug Discovery, Clinical Trials, Inflammatory Disorders |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 1989 | Not published |
| Headquarters | New York, United States | San Carlos, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Bristol Myers Squibb | ChemoCentryx |
|---|---|---|
| Employees | 38,080 | Not published |
| LinkedIn followers | 1,886,144 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bristol Myers Squibb | ChemoCentryx |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 22/100 | 6/100 |
| Traction | 20/100 | Not published |
| Team | 10/100 | Not published |
| Search visibility | 23/100 | 8/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 83/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bristol Myers Squibb | ChemoCentryx |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | CloudFront | Not detected |
| Analytics | Microsoft Clarity, Qualtrics | Not detected |
What users say
| Measure | Bristol Myers Squibb | ChemoCentryx |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 3 negative across 6 threads | Not published |
“Bristol Myers Squibb ist im Kurs gerade günstig und spuckt aktuell über 5% Rendite durch Dividende (vierteljährlich) im Jahr aus. Nichts aufregendes, aber ne solide Bank und nicht vergessen... mühsam ernährt sich das Eichhörnchen.”r/Aktien
Bristol Myers Squibb vs ChemoCentryx: common questions
Which is better, Bristol Myers Squibb or ChemoCentryx?
On our 0-100 score Bristol Myers Squibb rates higher (22/100 against 6/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do Bristol Myers Squibb and ChemoCentryx compare on the numbers?
Bristol Myers Squibb leads on our overall score (22/100 against 6/100), agent readiness (44/100 against 21/100), domain rating (83/100 against 32/100).
What do real users say about Bristol Myers Squibb and ChemoCentryx?
Bristol Myers Squibb: 2 positive and 3 negative mentions across 6 Reddit threads we track, mostly in r/Aktien.
Read the full Bristol Myers Squibb review and pricing or the ChemoCentryx review and pricing. You can also browse other Bristol Myers Squibb alternatives we track.